KETTIA ALUSMA-HIBBERT: Open Payments
NPI 1134628233 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,748 in 241 payments from 44 companies in 2025. Trend: 2023 $12,062 · 2024 $16,677 · 2025 $13,748
Food & beverage: $7,118Speaker / faculty: $2,321Travel & lodging: $1,803Honoraria: $1,650Consulting: $756Education: $100
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $4,506 |
| CATALYST PHARMACEUTICALS, INC. | 7 | $1,809 |
| GENZYME CORPORATION | 3 | $834 |
| UCB, Inc. | 18 | $724 |
| ARGENX US, INC. | 18 | $422 |
| Biogen, Inc. | 15 | $398 |
| EMD Serono, Inc. | 6 | $338 |
| Lilly USA, LLC | 7 | $334 |
| PFIZER INC. | 13 | $265 |
| Neurocrine BioSciences, Inc. | 6 | $251 |
Products named: HYQVIA, FIRDAPSE, Leqembi, VYVGART HYTRULO, ZEPOSIA, INGREZZA, ULTOMIRIS, Fintepla.
Industry payments across FL — which companies pay providers there.
